Peripheral Vascular Devices Market
Peripheral Vascular Devices Market Analysis by Angioplasty Stents, Angioplasty Balloon Catheters, EVAR Stent Grafts, Plaque Modification Devices, and Others from 2023 to 2033
Analysis of Peripheral Vascular Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Peripheral Vascular Devices Market Outlook (2023 to 2033)
Expanding at a CAGR of 4.5%, the global peripheral vascular devices market is projected to increase from a valuation of US$ 10.84 billion in 2023 to US$ 16.83 billion by the end of 2033.
Peripheral vascular devices are used to treat peripheral vascular diseases (PVDs), a circulation problem that develops slowly. PVD may be brought on by blood vessel spasms, blockages, or narrowing. PVDs also affect any blood arteries other than that of the heart, including the veins and lymphatic vessels. These veins supply blood to the legs and the brain, which may not be enough for them to function correctly. The legs and feet, on the other hand, are the body parts most often affected.
Another name for peripheral arterial disease is peripheral vascular disease. Surgical or minimally-invasive catheter-based procedures can be carried out using peripheral vascular devices.
Devices used to treat PVDs are angioplasty stents, angioplasty balloon catheters, endovascular aneurysm repair (EVAR) stent grafts, plaque modification devices, hemodynamic flow alteration devices, and inferior vena cava filters. Global demand for angioplasty stents is expected to rise at a CAGR of 5% from 2023 to 2033.
Sales of angioplasty stents are expected to be driven primarily by the growing prevalence of coronary artery diseases (CADs), which are brought on by a build-up of plaque in the artery and are treated with stents during percutaneous coronary interventions.
- For instance, research published in February 2022 by the Heart and Stroke Foundation of Canada estimates that there are 750,000 heart failure patients in the nation and that 100,000 new cases are expected to be reported annually by 2030.
The senior population, which is defined as those who are 65 years of age and older, is more susceptible to several chronic diseases such as cardiovascular disorders (CVDs), which must be treated surgically since they can cause plaque accumulation in the arteries.
- According to the Asian Pacific Observatory on Health Systems and Policies' November 2021 report, by 2050, one-fourth of the population in the Asia Pacific region will be 60 or older as a result of the region's declining fertility rate and increasing longevity, which is also anticipated to increase the burden of cardiovascular diseases and lead to a greater demand for effective and cutting-edge treatment procedures, such as the implantation of stents.
Report Attributes |
Details |
|
Peripheral Vascular Devices Market Size (2023E) |
US$ 10.84 Billion |
|
Forecasted Market Value (2033F) |
US$ 16.83 Billion |
|
Global Market Growth Rate (2023 to 2033) |
4.5% CAGR |
|
China Market Growth Rate (2023 to 2033) |
4% CAGR |
|
Japan Market Growth Rate (2023 to 2033) |
4% CAGR |
|
Germany Market Growth Rate (2023 to 2033) |
3% CAGR |
|
Canada Market Growth Rate (2023 to 2033) |
3.5% CAGR |
|
Key Companies Profiled |
|
What’s Benefitting Providers of Peripheral Vascular Devices?
“Technological Advancements in Treatment Procedures”
Currently, endovascular minimally-invasive techniques such as angioplasty or atherectomy, to maximize arterial opening size, are used more commonly than bypass surgeries as the first line of PAD treatment. The two main endovascular treatments for peripheral arterial disease are atherectomy and balloon angioplasty with stenting. Severe PAD patients may benefit from vascular surgeries or endovascular therapies.
The most serious type of peripheral vascular disease (PAD), critical limb ischemia (CLI), affects a sizable portion of the global population. Endovascular therapies are being accepted as the first treatment option.
The results of endovascular therapy have greatly improved over time. The adventitial delivery of anti-restenosis medications, paclitaxel-eluting stents, percutaneous femoral popliteal bypass, intravascular lithotripsy, and other novel methods are currently being developed.
The rapidly growing rate of the population is increasing the demand for healthcare services. Cardiovascular diseases mostly affect the elderly population, which is anticipated to increase the demand for peripheral vascular devices for treatment purposes. Also, several technological developments are having a positive influence on the sales of peripheral vascular devices.
“Rising Prevalence of Peripheral Artery Diseases”
A minimally-invasive procedure called peripheral artery revascularization can improve blood flow while causing less discomfort, scarring, and recovery time. Peripheral artery disease is caused due to the rising incidence of lifestyle disorders including obesity and diabetes linked to high cholesterol levels, which in turn has a positive influence on the development of peripheral arterial revascularization devices.
The main drivers of peripheral artery revascularization device sales are rising awareness of new treatment options and respective government attempts to enhance the healthcare sector. The demand for peripheral artery revascularization devices may see significant growth due to the use of new technologies and innovative vascularization methods.
- According to the American Heart Association's 2021 report, peripheral artery disease, which affects more than 200 million individuals worldwide, is linked to high mortality and morbidity.
The rapidly ageing world population is leading to increasing PAD cases in the coming years.
- According to a study published by the American Heart Association in August 2021 and named ‘Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions’, more than 230 million people worldwide are affected by lower extremity peripheral artery disease, which is associated with an increased risk of several unfavourable clinical outcomes (including cardiovascular disorders such as stroke and coronary heart disease and limb outcomes such as amputee status).
As a result, the prevalence of PAD is growing more quickly, which ultimately is boosting the market for peripheral vascular devices.
“Growing Demand for Advanced Peripheral Vascular Stents”
Stents were initially developed as metal alloy tubes that could be placed intraluminally. Recently, stents have undergone several changes, including the development of coated stents, bare metal stents, and drug-eluting stents. Stents could also be balloon expandable and self-expanding. The most common materials used to make stents nowadays are cobalt chromium, stainless steel, and a combination of nickel and titanium.
Bioabsorbable stents have been made using biodegradable polymers. Thus, the rising demand for advanced peripheral vascular stent grafts is generating new opportunities in the peripheral vascular devices market.
Why Should Peripheral Vascular Device Manufacturers Focus on Pricing Trends?
“High Cost of Cutting-edge Peripheral Vascular Medical Devices”
Peripheral vascular devices market growth is constrained by issues including the recalling of devices, strict device approval regulations, and the high prices of cutting-edge devices.
- Medtronic announced the FDA's Class I medical device recall in reaction to claims of traumas connected with its HawkOne system for unclogging arteries. Medtronic initiated the recollection in December 2021, affecting roughly 95,000 products that had been sold to Americans since 2018.
Furthermore, institutional settings have higher material costs for peripheral arterial devices, and the high adoption costs for these devices are hampering sales growth. Additionally, strict limitations on peripheral vascular surgical device use further may limit the market's potential growth.
There is a chance of restenosis developing following several operations involving drug-eluting balloons. The demand for peripheral vascular stents is expected to see growth restraint over the projected period, taking the aforementioned considerations into account.
Country-wise Analysis
What is the Demand Outlook for Peripheral Vascular Intervention Treatment Procedures in the United States?
“High Prevalence of Cardiac Disorders and Presence of Leading Manufacturers of Peripheral Vascular Devices”
The North American market is predicted to be dominated by the United States due to factors such as the rising prevalence of cardiovascular diseases, the ageing population, advanced healthcare infrastructure, public awareness of available technologies, and the concentration of market players in the United States.
- Heart illness is the leading cause of mortality in the United States, according to the article titled ‘Heart Disease Facts’ published by the Centers for Disease Control and Prevention (CDC) and released in September 2020.
- The same source states that roughly 805,000 Americans experience a heart attack each year.
Since peripheral vascular devices aid in the treatment of artery blockages and stenosis, they are anticipated to develop rapidly during the forecast period. The rising incidence of fatal heart diseases generates constant demand for the effective treatment of cardiac disorders.
- Siemens Healthineers introduced the next-generation ACUSON AcuNav Volume ICE Catheter in the United States in March 2022. The company asserts that by enabling patients who couldn't previously undergo structural heart procedures to receive treatment, the AcuNav Volume ICE catheter enhances the delivery of healthcare.
Thus, the introduction of next-generation devices in the nation is promoting product sales growth.
What is the Common Factor Driving the Sales of Peripheral Vascular Devices in Germany & France?
“Presence of Advanced Healthcare Systems”
Germany and France dominate the sales of peripheral vascular devices in the European region. The demand for peripheral vascular devices in Germany is expected to expand at a CAGR of 3% during the forecast period, as per industry analysis by Fact.MR, a market research and competitive intelligence provider.
The awareness of heart care, the high rate of heart diagnosis, and the presence of advanced healthcare facilities are all contributing to the market growth in Germany. For extra protection, guidewires are used during minimally-invasive cardiac surgeries. The use of cutting-edge technologies for the treatment of target disorders and favourable reimbursement initiatives are some of the major elements influencing sales of peripheral guidewires.
Since French surgeons are recognised globally for their expertise in minimally-invasive treatments, France has built training facilities for cardiovascular operations. Advancement in the medical sector and the rapidly rising medical tourism sector is boosting the France peripheral device market growth.
Which Diseases are Expected to Account for High Sales of Peripheral Vascular Devices in China & Japan?
“Increasing Cases of Diabetes & Heart-related Disorders”
The prevalence of diabetes is rising in China. Adults are at a high risk of experiencing diabetes. Diabetes aids several heart-related diseases, thus rising cases of diabetes are expected to boost the demand for peripheral vascular atherectomy devices.
- Over 11% of the adult population in china experiences diabetes, according to WHO.
- The same source estimates that by 2045 around 185 million people in China are going to be diabetes positive.
Japan is considered to have a high rate of senior population. More than 100 years of age individuals are recorded in Japan. The risk of cardiac disorders increases with age. Thus, the sales of peripheral vascular devices are expected to progress at a healthy pace in Japan.
- According to the National Cerebral and Cardiovascular Center of Japan, there were about 1.2 million heart failure patients in Japan by December 2021.
- According to World Data 2022, about 29% of Japan's population was 65 or older in 2021.
Category-wise Analysis
Why is the Prevalence of Peripheral Arterial Disease Rising across the World?
“Improper Diets and Intake of Tobacco & Alcohol”
Compared to other indications such as peripheral aneurysms, arteriovenous fistulas, etc., the prevalence of peripheral arterial disease is rising globally. As a result, the demand for peripheral arterial devices is growing at a rapid pace.
When blood flow to the arms or legs is decreased due to clogged or narrowed arteries is known as peripheral artery disease or peripheral arterial disease. Increasing urban lifestyle, high consumption of tobacco and alcohol, and lack of a healthy diet are some of the reasons for peripheral arterial disease.
Competitive Landscape
To increase and maintain their market position, key players in the peripheral vascular devices market are developing advanced devices. Mergers, acquisitions, partnerships, new developments in products, and enhancing local supply management systems are some of the marketing tactics adopted by market participants.
- Abbott announced the acquisition of Walk Vascular, an LLC, manufacturer of medical devices featuring a minimally-invasive mechanical aspiration peripheral venous thrombectomy device for the removal of peripheral blood clots, in September 2021. Abbott included Walk Vascular's peripheral thrombectomy systems in its current endovascular product line. Through the partnership, Abbott expanded the scope of its peripheral vascular devices and accessories.
- Cardio Flow, Inc., manufacturer of minimally-invasive peripheral vascular devices for the treatment of peripheral artery disease, announced in June 2022 that the FreedomFlow Peripheral Guidewire has received FDA approval.
Key Segments of Peripheral Vascular Devices Industry Research
-
By Type :
- Angioplasty Stents
- Angioplasty Balloon Catheters
- Endovascular Aneurysm Repair (EVAR) Stent Grafts
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Inferior Vena Cava Filters
-
By Indication :
- Target Artery Instabilities (TAIs)
- Access Artery Injuries (AAIs)
- Peripheral Arterial Diseases
- Arteriovenous Fistulas
- Peripheral Aneurysms
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Labs
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Type Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Peripheral Vascular Devices 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Type, 2018 to 2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Type, 2023 to 2033 6.3.1. Angioplasty Stents 6.3.2. Angioplasty Balloon Catheters 6.3.3. Endovascular Aneurysm Repair (EVAR) Stent Grafts 6.3.4. Plaque Modification Devices 6.3.5. Hemodynamic Flow Alteration Devices 6.3.6. Inferior Vena Cava Filters 6.4. Market Attractiveness Analysis By Type 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Indication 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Indication , 2018 to 2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Indication, 2023 to 2033 7.3.1. Target Artery Instabilities (TAIs) 7.3.2. Access Artery Injuries (AAIs) 7.3.3. Peripheral Arterial Diseases 7.3.4. Arteriovenous Fistulas 7.3.5. Peripheral Aneurysms 7.4. Market Attractiveness Analysis By Indication 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.3.3. Cardiac Catheterization Labs 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Type 10.3.3. By Indication 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Type 10.4.3. By Indication 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Type 11.3.3. By Indication 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Type 11.4.3. By Indication 11.4.4. By End User 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Type 12.3.3. By Indication 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Type 12.4.3. By Indication 12.4.4. By End User 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Type 13.3.3. By Indication 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Type 13.4.3. By Indication 13.4.4. By End User 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Type 14.3.3. By Indication 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Type 14.4.3. By Indication 14.4.4. By End User 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Type 15.3.3. By Indication 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Type 15.4.3. By Indication 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Abbott Laboratories 17.3.1.1. Company Overview 17.3.1.2. Type overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. B. Braun Melsungen AG 17.3.2.1. Company Overview 17.3.2.2. Type overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. BARD, A Becton, Dickinson Company 17.3.3.1. Company Overview 17.3.3.2. Type overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Biosensors International Group Ltd. 17.3.4.1. Company Overview 17.3.4.2. Type overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Biotronik SE & Co. KG 17.3.5.1. Company Overview 17.3.5.2. Type overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Boston Scientific Corporation 17.3.6.1. Company Overview 17.3.6.2. Type overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Cordis Corporation 17.3.7.1. Company Overview 17.3.7.2. Type overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. iVascular S.L.U 17.3.8.1. Company Overview 17.3.8.2. Type overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Medtronic PLC 17.3.9.1. Company Overview 17.3.9.2. Type overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Terumo Corporation 17.3.10.1. Company Overview 17.3.10.2. Type overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 2: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 4: Global Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 5: Global Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Indication, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Indication, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Indication, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 4: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 5: Global Market Share and BPS Analysis by Type, 2023 & 2033
Figure 6: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 7: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 8: Global Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 9: Global Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Type, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Type, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Type, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Type, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Indication, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Indication, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the value of the peripheral vascular devices market in 2023?
The global peripheral vascular devices market is valued at US$ 10.84 billion in 2023.
What is the sales forecast for the peripheral vascular devices market by 2033?
Global demand for peripheral vascular devices is predicted to reach US$ 16.83 billion by 2033.
What is the expected growth rate of the peripheral vascular devices market?
Worldwide sales of peripheral vascular devices are expected to increase at a CAGR of 4.5% during the forecast.
Which is the dominating regional market for peripheral vascular device suppliers?
North America is considered to be a leading market for peripheral vascular devices.
Who are the key players in the peripheral vascular devices market sphere?
Abbott Laboratories, Boston Scientific Corporation, Cook Medical Inc., and B. Braun Melsungen AG are leading manufacturers of peripheral vascular devices.
Peripheral Vascular Devices Market